Reimbursement for therapeutic apheresis devices and procedures for using the healthcare insurance system in Japan

The aim of this paper was to explain the insurance coverage status of therapeutic apheresis (excluding CHDF) in Japan, alongside the social system of medical reimbursement and concerns regarding the future sustainability of the healthcare system. Insurance schemes and premiums differed for individua...

Descripción completa

Detalles Bibliográficos
Autores principales: Kusaoi, Makio, Murayama, Go, Tamura, Naoto, Yamaji, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540553/
https://www.ncbi.nlm.nih.gov/pubmed/32567164
http://dx.doi.org/10.1111/1744-9987.13550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540553/
https://www.ncbi.nlm.nih.gov/pubmed/32567164
http://dx.doi.org/10.1111/1744-9987.13550

Ejemplares similares